Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children

Paul A. Shurin, James M. Rehmus, Candice E. Johnson, Colin D. Marchant, Susan A. Carlin, Dennis M. Super, George F. Van Hare, Paul K. Jones, Donna M. Ambrosino, George R. Siber

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Abstract

We evaluated the prevention of recurrences of acute otitis media (AOM) bybacterial polysaccharide immune globulin (BPIG), a hyperimmune human immune globulin prepared by immunizing donors with bacterial polysaccharide vaccines. We used a randomized, stratified, double-blind, placebo-controlied design. Children ≤24 months of age with 1 to 3 prior episodes of AOM received BPIG, 0.5 ml/kg, or saline placebo intramuscularly at entry and 30 days later. During the 120-day follow-up period, AOM was diagnosed by using clinical criferia and was confimed with tympanocentesis and culture of the middle ear exudates. Eighty-eight episodes of AOM were observed in 76 patients who completed the study. The incidence of AOM during the entire 120-day study period was similar in BPIG and placebo recipients. Pneumococcal AOM was significantly less frequent in BPIG reciplents (0.21 episode per patient) than in placebo recipients (0.45 episode per patient; p=0.05). Time spent free of AOM was significantly prolonged in recipients of BPIG., in comparison with placebo recipients (51 vs 35 days: p=0.034). This study demonstrated that circulating antibody, even without stimulation of specific local immunity, may prevent infection of the middle ear. The use of immune globulin preparations for longer periods or at a higher dosage might decrease the incidence of recurrent AOM in otitis-prone children, and deserves further evaluation.

Original languageEnglish
Pages (from-to)801-810
Number of pages10
JournalThe Journal of Pediatrics
Volume123
Issue number5
DOIs
StatePublished - Nov 1993

Fingerprint

Dive into the research topics of 'Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children'. Together they form a unique fingerprint.

Cite this